Try it
Dermatology · Pigmentary disorders: tranexamic acid in melasma
Sample itemWhich patient should NOT receive oral tranexamic acid for refractory melasma?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. A woman with a history of deep vein thrombosis
Oral tranexamic acid is an antifibrinolytic that can reduce melasma, but it is contraindicated in patients with a history of venous or arterial thromboembolism or high thrombotic risk. Oestrogen use adds to the risk. It is used in short courses with photoprotection.
Option by option
A. A woman with a history of deep vein thrombosis (correct)
Correct. Prior deep vein thrombosis is a contraindication.
B. A woman using sunscreen
Sunscreen use is encouraged.
C. A woman with mild acne
Acne does not contraindicate it.
D. A woman with seasonal allergic rhinitis
Allergic rhinitis does not contraindicate it.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Dermatology questions
- Blistering disordersA patient has flaccid blisters that rupture easily and a positive Nikolsky sign. Which c…
- LeprosyIn which type of leprosy is the lepromin test strongly positive?
- Pigmentary disordersA man has well-demarcated chalk-white macules on his hands and around his mouth. A skin…
- Drug reactionsWhich of the following drugs is a well-recognised trigger of Stevens–Johnson syndrome an…